About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(tetO-Ipf1,EGFP)956.6Macd
transgene insertion 956-6, Raymond J MacDonald
MGI:3655514
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Pdx1tm1Macd/Pdx1tm1Macd
Tg(tetO-Ipf1,EGFP)956.6Macd/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL MGI:3655708


Genotype
MGI:3655708
cx1
Allelic
Composition
Pdx1tm1Macd/Pdx1tm1Macd
Tg(tetO-Ipf1,EGFP)956.6Macd/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pdx1tm1Macd mutation (1 available); any Pdx1 mutation (35 available)
Tg(tetO-Ipf1,EGFP)956.6Macd mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• in doxycycline-treated mice there is an increase in glucagons-positive cells
• there is a marked reduction in insulin in pancreata of doxycycline-treated mice; after withdrawal of doxycycline, insulin +ve cells are detected in islets of smaller islet-like cell clusters
• 14 days after doxycycline withdrawal after 14 days of treatment resulted in a significant decrease in blood glucose levels with 4/5 mice becoming normoglycemic by 28 days
• with doxycycline treatment for 21 day, adult rescue mice show a 4-fold increase in fasting blood glucose to diabetic levels
• adult transgenic rescue animals treated with doxycycline for 14 days exhibit a defective response to glucose challenge compared to wild-type, non mutant transgenic, or untreated rescue mice (J:79206)
• when adult mice are treated with doxycycline for 0, 7, 14, or 21 days, mice show an increased early glucose response within 7 days of start of treatment and ability to recover from glucose challenge is impaired compared to untreated transgenics where glucose levels recover to basal levels within 3 hours; by 14 days of doxycycline treatment, mice have diabetes (J:101742)

endocrine/exocrine glands
• after 14 or 28 days of dox treatment there are, still present, beta cells which lack insulin
• after dox treatment for 14 days, there is a significant decrease in islet area compared to wild-type
• pancreas of transgenic rescue newborn mice is 50% the size of a normal wild-type neonatal pancreas
• treatment of pregnant mice with doxycycline from the first day of pregnancy through parturition prevents formation of the pancreas in mice with the transgenic rescue genotype
• treatment on E11.5 arrests pancreatic development ~36 hours later; at birth the underdeveloped remnant consisted of a large and extended duct with several terminal, aborted, ductal buds with ducts lined with a single layer of primitive epithelial cells and with no acinar or islet tissue
• in doxycycline-treated mice there is an increase in glucagons-positive cells
• there is a marked reduction in insulin in pancreata of doxycycline-treated mice; after withdrawal of doxycycline, insulin +ve cells are detected in islets of smaller islet-like cell clusters

cellular
• foci of duct proliferation are present in mice after 14 days of doxycycline treatment and become more prominent with continued treatment





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/19/2024
MGI 6.23
The Jackson Laboratory